Abstract:The final, formatted version of the article will be published soon. You have multiple emails registered with Frontiers: Please enter your email address: If you already have an account, please login You don't have a Frontiers account ? You can register here Background: Ulcerative colitis has a serious impact on the quality of life of patients and is more likely to progress to colon cancer. Therefore, early diagnosis and timely intervention are of considerable importance. Methods: Gene expression data of active ulcerative colitis were downloaded from the Gene Expression Omnibus (GEO)database, and genes with significant differential expression were identified. Biochemical markers with diagnostic significance were selected through machine learning methods. The expression differences of the selected markers between colon adenocarcinoma (COAD) and healthy control groups in The Cancer Genome Atlas (TCGA) database were analyzed to evaluate their diagnostic value. In addition, the correlation between the selected markers and clinical indicators, as well as their predictive efficacy for the survival of COAD patients, was explored. Results: Through machine learning and LASSO regression analysis, UGT2A3 was finally determined as a diagnostic marker for ulcerative colitis. It demonstrated high diagnostic accuracy in both the training set and the external validation set. Furthermore, UGT2A3 was significantly downregulated in COAD tissues compared to normal control tissues. The ROC curve suggested that UGT2A3 could serve as a diagnostic marker for COAD with excellent performance, achieving an AUC of 0.969. Immune infiltration analysis indicated a significant negative correlation between the expression of UGT2A3 and neutrophils. Correlation analysis suggested a link between UGT2A3 and the pathological classification of colon cancer. Survival analysis showed that UGT2A3 is negatively correlated with OS, PPS, and RFS in colon cancer. Conclusion: The author identified UGT2A3 as a diagnostic marker for ulcerative colitis through bioinformatics methods, and verified its significant downregulation in colon cancer, as well as its predictive role in the survival of COAD patients. These findings suggest that UGT2A3 may serve not only as a diagnostic marker for ulcerative colitis and colon cancer but also as a potential prognostic indicator for colon cancer.

[The UGT1A, Nrf2 and Keap1 Protein Expression and Significance in Colon Tumor].

[Association Between Genetic Polymorphisms of Metabolic Enzymes and Susceptibility of Colorectal Cancer].

[A Case-Control Study on the Association Between Genetic Polymorphisms of Metabolic Enzymes and the Risk of Colorectal Cancer].

[Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]

Mkp-1 is required for chemopreventive activity of butylated hydroxyanisole and resveratrol against colitis-associated colon tumorigenesis.

Overexpression of Glucose-Regulated Protein 78 in Colon Cancer.

UTP18-mediated p21 mRNA instability drives adenoma-carcinoma progression in colorectal cancer

Expression of Drug Resistance-associated Tumor Genes in Human Colonic Carcinoma Tissue and its Clinical Significance

Expression and Significance of URP1 in Colon Carcinoma

UDP-glucuronosyltransferases 2A3 as a biomarker for ulcerative colitis and colon cancer

The Expression Profiles and Deregulation of UDP-Glycosyltransferase (UGT) Genes in Human Cancers and Their Association with Clinical Outcomes

USP18 promotes colon adenocarcinoma progression via targeting the ERK-MNK signaling pathway

UGT1A Gene Family Members Serve As Potential Targets and Prognostic Biomarkers for Pancreatic Cancer

Inhibition of Kelch-like epichlorohydrin-related protein 1 promotes the progression and drug resistance of lung adenocarcinoma

Impact of CDKN2A gene expression on colon adenocarcinoma via biosignature analysis

Influence of P57kip2 and Ki67 Expression on Invasive Properties of Colon Adenocarcinoma

Association Between the Expression Levels of TAZ, AXL and CTGF and Clinicopathological Parameters in Patients with Colon Cancer

Transforming Growth Factors and Receptor As Potential Modifiable Pre-Neoplastic Biomarkers of Risk for Colorectal Neoplasms

A study on the genomic alterations of transformation from colorectal adenoma to colorectal cancer.

Clinical significance of tumor suppressor PTEN in colorectal carcinoma

Fucosyltransferases Regulated by Fusobacterium Nucleatum and Act as Novel Biomarkers in Colon Adenocarcinoma